Analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a "hold" rating on the stock.
Milestone Scientific Stock Down 6.9 %
NYSE:MLSS traded down $0.08 during trading hours on Friday, reaching $1.02. 62,616 shares of the stock were exchanged, compared to its average volume of 156,531. The firm has a 50 day simple moving average of $1.11 and a 200-day simple moving average of $0.96. Milestone Scientific has a 52 week low of $0.54 and a 52 week high of $1.39. The stock has a market capitalization of $79.06 million, a P/E ratio of -14.50 and a beta of 1.41.
Hedge Funds Weigh In On Milestone Scientific
Several large investors have recently made changes to their positions in the business. Y Intercept Hong Kong Ltd purchased a new position in Milestone Scientific during the 3rd quarter valued at about $48,000. Geode Capital Management LLC lifted its holdings in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock worth $480,000 after buying an additional 31,572 shares during the last quarter. World Investment Advisors LLC bought a new stake in shares of Milestone Scientific in the 3rd quarter worth approximately $91,000. Carnegie Investment Counsel boosted its holdings in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock valued at $166,000 after purchasing an additional 27,412 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after buying an additional 53,198 shares in the last quarter. Institutional investors own 5.79% of the company's stock.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
